Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and reactogenicity of Influvac 2007/2008 in healthy adults and elderly
2007-000875-40Phase 3Completed
- Sponsor
- Solvay Pharmaceuticals
- Start
- Apr 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of influenza vaccine in influenza (2 arms), sponsored by Solvay Pharmaceuticals. Primary endpoint: Hemagglutination inhibition (HI) antibody titers. Started Apr 2007; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2007-000875-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000875-40.